Expression of transcription factor Sox9 in rat L6 myoblastic cells

Connective Tissue Research

Volumn 45, Issue 3, 2004, Pages 164-173

  Matsushita, Takehiko ^a   Matsui, Nobuzo ^a   Fujioka, Hiroyuki ^a   Kubo, Seiji ^a   Kuroda, Ryosuke ^a   Kurosaka, Masahiro ^a   Yoshiya, Shinichi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Myoblast; Sox9; TGF 3

Indexed keywords

COLLAGEN TYPE 2; DEXAMETHASONE; MESSENGER RNA; MYOGENIC FACTOR; MYOGENIC FACTOR 5; MYOGENIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARTILAGE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELL STIMULATION; CHONDROGENESIS; CONTROLLED STUDY; GENE EXPRESSION; MYOBLAST; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CHONDROGENESIS; COLLAGEN TYPE II; DNA-BINDING PROTEINS; GENE EXPRESSION; GENES, REGULATOR; HIGH MOBILITY GROUP PROTEINS; MUSCLE DEVELOPMENT; MUSCLE PROTEINS; MYOBLASTS; MYOGENIC REGULATORY FACTOR 5; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3;

EID: 7244257607     PISSN: 03008207     EISSN: None     Source Type: Journal    
DOI: 10.1080/03008200490514130     Document Type: Article

References (46)

1. Urist, M.R. (1965). Bone: Formation by autoinduction. Science 150:893-899.
2. Nathanson, M.A., and Hay, E.D. (1980). Analysis of cartilage differentiation from skeletal muscle grown on bone matrix. I. Ultrastructural aspects. Dev. Biol. 78:301-331.
3. Nathanson, M.A., and Hay, E.D. (1980). Analysis of cartilage differentiation from skeletal muscle grown on bone matrix. II. Chondroitin sulfate synthesis and reaction to exogenous glycosaminoglycans. Dev. Biol. 78:332-351.
4. Nogami, H., and Urist, M.R. (1974). Substrata prepared from bone matrix for chondrogenesis in tissue culture. J. Cell Biol. 62:510-519.
5. Bettex-Galland, M., and Wisemann, U. (1987). Differentiation of L6 myoblastic cells into chondrocytes. Experientia 43:610-611.
6. Iwata, H., Ono, S., Sato, K., Sato, T., and Kawamura, M. (1993). Bone morphogenetic protein-induced muscle- and synovium-derived cartilage differentiation in vitro. Clin. Orthop. 296:295-300.
7. Aikawa, T., Shirasuna, K., Iwamoto, M., Watatani, K., Nakamura, T., Okura, M., Yoshioka, H., and Matsuya, T. (1996). Establishment of bone morphogenetic protein 2 responsive chondrogenic cell line. J. Bone Miner. Res. 11:544-553.
8. Young, H.E., Steele, T.A., Bray, R.A., Hudson, J., Floyd, J.A., Hawkins, K., Thomas, K., Austin, T., Edwards, C., Cuzzourt, J., Duenzl, M., Lucas, P.A., and Black, A.C. (2001). Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat. Rec. 264:51-62.
9. Sudbeck, P., Schmitz, M.L., Baeuerle, P.A., and Scherer, G. (1996). Sex reversal by loss of the C-terminal transactivation domain of human SOX-9. Nat. Genet. 13:230-232.
10. Kent, J., Wheatley, S.C., Andrews, J.E., Sinclair, A.H., and Koopman, P. (1996). A male-specific role for SOX9 in vertebrate sex determination. Development 122:2813-2822.
11. Lefebvre, V., and de Crombrugghe, B. (1998). Toward understanding SOX9 function in chondrocyte differentiation. Matrix. Biol. 16:529-540.
12. Foster, J.W., Dominguez-Steglich, M.A., Guioli, S., Kowk, G., Weller, P.A., Stevanovic, M., Weissenbach, J., Mansour, S., Young, I.D., Goodfellow, P.N., Brook, J.D., and Schafer, A.J. (1994). Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372:525-530.
13. Wagner, T., Wirth, J., Meyer, J., Zabel, B., Held, M., Zimmer, J., Pasantes, J., Bricarelli, F.D., Keutel, J., and Hustert, E. (1994). Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79:1111-1120.
14. Lefebvre, V., Huang, W., Harley, V.R., Goodfellow, P.N., and de Crombrugghe, B. (1997). SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol. Cell Biol. 17:2336-2346.
15. Wright, E., Hargrave, M.R., Christiansen, J., Cooper, L., Kun, J., Evans, T., Gangadharan, U., Greenfield, A., and Koopman, P. (1995). The SRY-related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nat. Genet. 9:15-20.
16. Zhao, Q., Eberspaecher, H., Lefebvre, V., and de Crombrugghe, B. (1997). Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev. Dyn. 209:377-386.
17. Ng, L.J., Wheatley, S., Muscat, G.E., Conway-Campbell, J., Bowles, J., Wright, E., Bell, D.M., Tam, P.P., Cheah, K.S., and Koopman, P. (1997). SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev. Biol. 183:108-121.
18. Bell, D.M., Leung, K.K., Wheatley, S.C., Ng, L.J., Zhou, S., Ling, K.W., Sham, M.H., Koopman, P., Tam, P.P., and Cheah, K.S. (1997). SOX9 directly regulates the type-II collagen gene. Nat. Genet. 16:174-178.
19. Rudnicki, M.A., Schnegelsberg, P.N., Stead, R.H., Braun, T., Arnold, H.H., and Jaenisch, R. (1993). MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75:1351-1359.
20. Ludolph, D.C., and Konieczny, S.F. (1995). Transcription factor families: Muscling in on the myogenic program. FASEB J. 9:1595-1604.
21. Yun, K., and Wold, B. (1996). Skeletal muscle determination and differentiation: Story of a core regulatory network and its context. Curr. Opin. Cell Biol. 8:877-889.
22. Yablonka-Reuveni, Z., and Rivera, A.J. (1994). Temporal expression of regulatory and structural proteins during myogenesis of satellite cells on isolated adult rat fibers. Dev. Biol. 164:588-603.
23. Seyedin, S.M., Thompson, A.Y., Bentz, H., Rosen, D.M., McPherson, J.M., Conti, A., Siegel, N.R., Galluppi, G.R., and Piez, K.A. (1986). Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta. J. Biol. Chem. 261:5693-5695.
24. Mackay, A.M., Beck, S.C., Murphy, J.M., Barry, F.P., Chichester, C.O., and Pittenger, M.F. (1998). Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng. 4:415-428.
25. Yaffe, D. (1968). Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc. Natl. Acad. Sci. USA 61:477-483.
26. Veis, A., Tompkins, K., Alvares, K., Wei, K., Wang, L., Wang, X.S., Brownell, A.G., Jengh, S.M., and Healy, K.E. (2000). Specific amelogenin gene splice products have signaling effects on cells in culture and in implants in vivo. J. Biol. Chem. 275:41263-41272.
27. Hanada, K., Solchaga, L.A., Caplan, A.I., Hering, T.M., Goldberg, V.M., Yoo, J.U., and Johnstone, B. (2001). BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis. J. Cell. Biochem. 81:284-294.
28. Graves, D.C., and Yablonka-Reuveni, Z. (2000). Vascular smooth muscle cells spontaneously adopt a skeletal muscle phenotype: A unique Myf5(-)/MyoD(+) myogenic program. J. Histochem. Cytochem. 48:1173-1193.
29. Tei, M., Moccia, R., and Gipson, I.K. (1999). Developmental expression of mucin genes ASGP (rMuc4) and rMuc5ac by the rat ocular surface epithelium. Invest. Ophthalmol. Vis. Sci. 40:1944-1951.
30. Taylor, S.M., and Jones, P.A. (1979). Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 17:771-779.
31. Grigoriadis, A.E., Heersche, J.N., and Aubin, J.E. (1988). Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: Effect of dexamethasone. J. Cell Biol. 106:2139-2151.
32. Grigoriadis, A.E., Heersche, J.N., and Aubin, J.E. (1990). Continuously growing bipotential and monopotential myogenic, adipogenic, and chondrogenic subclones isolated from the multipotential RCJ 3.1 clonal cell line. Dev. Biol. 142:313-338.
33. Yamaguchi, A., and Kahn, A.J. (1991). Clonal osteogenic cell lines express myogenic and adipocytic developmental potential. Calcif. Tissue. Int. 49:221-225.
34. Pittenger, M.F., Mackay, A., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
35. Asakura, A., Komaki, M., and Rudnicki, M. (2001). Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 68:245-253.
36. Yeh, L.C., Tsai, A.D., and Lee, J.C. (2002). Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12. J. Cell Biochem. 87:292-304.
37. Katagiri, T., Yamaguchi, A., Komaki, M., Abe, E., Takahashi, N., Ikeda, T., Rosen, V., Wozney, J.M., Fujisawa-Sehara, A., and Suda, T. (1994). Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127:1755-1766.
38. Teboul, L., Gaillard, D., Staccini, L., Inadera, H., Amri, E.Z., and Grimaldi, P.A. (1995). Thiazolidinediones and fatty acids convert myogenic cells into adipose-like cells. J. Biol. Chem. 270:28183-28187.
39. Schmidt, K., Glaser, G., Wernig, A., Wegner, M., and Rosorius, O. (2003). Sox8 is a specific marker for muscle satellite cells and inhibits myogenesis. J. Cell Physiol. 196:70-78.
40. Aigner, T., Gebhard, P.M., Schmid, E., Bau, B., Harley, V., and Poschl, E. (2003). SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes. Matrix Biol. 4:363-372.
41. Sekiya, I., Vuoristo, J.T., Larson, B.L., and Prockop, D.J. (2002). In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc. Natl. Acad. Sci. USA 7:4397-4402.
42. Lee, M. H., Javed, A., Kim, H.J., Shin, H.I., Gutierrez, S., Choi, J.Y., Rosen, V., Stein, J.L., van Wijnen, A.J., Stein, G.S., Lian, J.B., and Ryoo, H.M. (1999). Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J. Cell Biochem. 73:114-125.
43. Stewart, J.D., Masi, T.L., Cumming, A.E., Molnar, G.M., Wentworth, B.M., Sampath, K., McPherson, J.M., and Yaeger, P.C. (2003). Characterization of proliferating human skeletal muscle-derived cells in vitro: Differential modulation of myoblast markers by TGF-beta2. J Biol. Chem. 278:29769-29775.
44. Johnstone, B., Hering, T.M., Caplan, A.I., Goldberg, V.M., and Yoo, J.U. (1998). In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 238:265-272.
45. Sekiya, I., Colter, D.C., and Prockop, D.J. (2001). BMP-6 enhances chondrogenesis in a subpopulation of human marrow stromal cells. Biochem. Biophys. Res. Commun. 284:411-418.
46. Yoo, J.U., Barthel, T.S., Nishimura, K., Solchaga, L., Caplan, A.I., Goldberg, V.M., and Johnstone, B. (1998). The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J. Bone Joint. Surg. Am. 80:1745-1757.